
FSD Pharma Inc. (NASDAQ: HUGE) entered into an agreement with Tekkfund Capital Corp to structure and assist “with certain business development strategies.”
During the duration of this agreement, the company will pay Tekkfund a monthly fee of around CA$12,500 ($9696,75) as well as monthly issuance of 7,000 Class B subordinate voting shares. The initial duration of the agreement will be 24 months.